XML 44 R31.htm IDEA: XBRL DOCUMENT v3.8.0.1
Business Segment and Geographical Information (Tables)
12 Months Ended
Dec. 31, 2017
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
Business Segment Information
(In millions)
 
2017

 
2016

 
2015

 
 
 
 
 
 
 
Revenues
 
 
 
 
 
 
Life Sciences Solutions
 
$
5,728

 
$
5,317

 
$
4,774

Analytical Instruments
 
4,821

 
3,668

 
3,208

Specialty Diagnostics
 
3,486

 
3,339

 
3,244

Laboratory Products and Services
 
7,825

 
6,724

 
6,372

Eliminations
 
(942
)
 
(774
)
 
(633
)
 
 
 
 
 
 
 
Consolidated revenues
 
20,918

 
18,274

 
16,965

 
 
 
 
 
 
 
Segment Income (a)
 
 
 
 
 
 
Life Sciences Solutions
 
1,896

 
1,596

 
1,414

Analytical Instruments
 
1,027

 
745

 
613

Specialty Diagnostics
 
930

 
910

 
873

Laboratory Products and Services
 
1,007

 
971

 
922

 
 
 
 
 
 
 
Subtotal reportable segments (a)
 
4,860

 
4,222

 
3,822

 
 
 
 
 
 
 
Cost of revenues charges
 
(123
)
 
(102
)
 
(9
)
Selling, general and administrative charges, net
 
(78
)
 
(104
)
 
(46
)
Restructuring and other costs, net
 
(97
)
 
(189
)
 
(116
)
Amortization of acquisition-related intangible assets
 
(1,594
)
 
(1,378
)
 
(1,315
)
 
 
 
 
 
 
 
Consolidated operating income
 
2,968

 
2,449

 
2,336

Other expense, net (b)
 
(539
)
 
(425
)
 
(400
)
 
 
 
 
 
 
 
Income from continuing operations before income taxes
 
$
2,429

 
$
2,024

 
$
1,936

 
 
 
 
 
 
 
Depreciation
 
 
 
 
 
 
Life Sciences Solutions
 
$
129

 
$
142

 
$
147

Analytical Instruments
 
71

 
50

 
39

Specialty Diagnostics
 
72

 
70

 
74

Laboratory Products and Services
 
167

 
118

 
113

 
 
 
 
 
 
 
Consolidated depreciation
 
$
439

 
$
380

 
$
373

(a)
Represents operating income before certain charges to cost of revenues and selling, general and administrative expenses; restructuring and other costs, net; and amortization of acquisition-related intangibles.
(b)
The company does not allocate other expense, net to its segments.
(In millions)
 
2017

 
2016

 
2015

 
 
 
 
 
 
 
Total Assets
 
 
 
 
 
 
Life Sciences Solutions
 
$
19,063

 
$
19,065

 
$
18,537

Analytical Instruments
 
9,960

 
9,520

 
4,763

Specialty Diagnostics
 
7,095

 
6,802

 
7,183

Laboratory Products and Services
 
19,181

 
9,405

 
9,614

Corporate/Other (c)
 
1,370

 
1,116

 
737

 
 
 
 
 
 
 
Consolidated total assets
 
$
56,669

 
$
45,908

 
$
40,834

 
 
 
 
 
 
 
Capital Expenditures
 
 
 
 
 
 
Life Sciences Solutions
 
$
118

 
$
122

 
$
93

Analytical Instruments
 
56

 
34

 
60

Specialty Diagnostics
 
87

 
72

 
76

Laboratory Products and Services
 
178

 
111

 
90

Corporate/Other
 
69

 
105

 
104

 
 
 
 
 
 
 
Consolidated capital expenditures
 
$
508

 
$
444

 
$
423

(c)
Corporate assets consist primarily of cash and cash equivalents, short-term investments, property and equipment at the company's corporate offices.
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]
Business Segment Information
(In millions)
 
2017

 
2016

 
2015

 
 
 
 
 
 
 
Revenues
 
 
 
 
 
 
Life Sciences Solutions
 
$
5,728

 
$
5,317

 
$
4,774

Analytical Instruments
 
4,821

 
3,668

 
3,208

Specialty Diagnostics
 
3,486

 
3,339

 
3,244

Laboratory Products and Services
 
7,825

 
6,724

 
6,372

Eliminations
 
(942
)
 
(774
)
 
(633
)
 
 
 
 
 
 
 
Consolidated revenues
 
20,918

 
18,274

 
16,965

 
 
 
 
 
 
 
Segment Income (a)
 
 
 
 
 
 
Life Sciences Solutions
 
1,896

 
1,596

 
1,414

Analytical Instruments
 
1,027

 
745

 
613

Specialty Diagnostics
 
930

 
910

 
873

Laboratory Products and Services
 
1,007

 
971

 
922

 
 
 
 
 
 
 
Subtotal reportable segments (a)
 
4,860

 
4,222

 
3,822

 
 
 
 
 
 
 
Cost of revenues charges
 
(123
)
 
(102
)
 
(9
)
Selling, general and administrative charges, net
 
(78
)
 
(104
)
 
(46
)
Restructuring and other costs, net
 
(97
)
 
(189
)
 
(116
)
Amortization of acquisition-related intangible assets
 
(1,594
)
 
(1,378
)
 
(1,315
)
 
 
 
 
 
 
 
Consolidated operating income
 
2,968

 
2,449

 
2,336

Other expense, net (b)
 
(539
)
 
(425
)
 
(400
)
 
 
 
 
 
 
 
Income from continuing operations before income taxes
 
$
2,429

 
$
2,024

 
$
1,936

 
 
 
 
 
 
 
Depreciation
 
 
 
 
 
 
Life Sciences Solutions
 
$
129

 
$
142

 
$
147

Analytical Instruments
 
71

 
50

 
39

Specialty Diagnostics
 
72

 
70

 
74

Laboratory Products and Services
 
167

 
118

 
113

 
 
 
 
 
 
 
Consolidated depreciation
 
$
439

 
$
380

 
$
373

(a)
Represents operating income before certain charges to cost of revenues and selling, general and administrative expenses; restructuring and other costs, net; and amortization of acquisition-related intangibles.
(b)
The company does not allocate other expense, net to its segments.
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]
Geographical Information
(In millions)
 
2017

 
2016

 
2015

 
 
 
 
 
 
 
Revenues (d)
 
 
 
 
 
 
United States
 
$
10,177

 
$
9,086

 
$
8,607

China
 
2,058

 
1,730

 
1,376

Other
 
8,683

 
7,458

 
6,982

 
 
 
 
 
 
 
Consolidated revenues
 
$
20,918

 
$
18,274

 
$
16,965

 
 
 
 
 
 
 
Long-lived Assets (e)
 
 
 
 
 
 
United States
 
$
2,349

 
$
1,630

 
$
1,532

United Kingdom
 
277

 
217

 
261

Other
 
1,421

 
731

 
656

 
 
 
 
 
 
 
Consolidated long-lived assets
 
$
4,047

 
$
2,578

 
$
2,449

(d)
Revenues are attributed to countries based on customer location.
(e)
Includes property, plant and equipment, net